CEO Message


Meeting the Growing Need for Advanced Analytical Services

March 27, 2023

As I look across the market, I see increasing demand for advanced analytical services to support new modalities and biological entities. Yet, as the need for advanced analytical services escalates, many biopharmaceutical organizations cannot add team members to meet the demand.

I’m honored that many global pharmaceutical and biotechnology organizations are turning to ProtaGene. These companies rely on us because we specialize in supporting molecules that defy convention, and we enjoy collaborating with our clients to tackle tough projects.

Additionally, due to strategic investments like launching our brand-new, state-of-the-art laboratory in the Burlington Bio Center and building out our leadership team, we are better positioned to provide analytical services to life sciences organizations that may lack specific in-house capabilities or perhaps need a stable and reliable partner to serve as an extension of their in-house capacity.

We’ve also been working hard to offer new solutions, like expanding Integration Site Analysis (ISA) capabilities to our new Boston-area lab and wait-free biodistribution and vector shedding analysis capabilities.

There is a lot to be excited about, and we’re looking forward to working with you to advance your therapeutic innovations.


Raymond Kaiser, PhD
Chief Executive Officer